 |
New Report on Nanometrology | The concept of nanometrology is introduced and defined in the first part of this report. Its importance is highlighted through an introduction to size – property relationships, which is the key aspect of nanometrology. Nanotechnology and nanosciences exploit and study new phenomena that appear when some characteristic structure of a material is in the nanometre size range. It is obvious that a key element of nanometrology is to measure dimensions in the range 1 to about 100 nm (with precision reaching 0.1 nm nowadays), and to correlate the measured size with properties.
...
More > >
|
 Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering; US2006085063, April 2006
Electrostatically driven carbon nanotube gripping device; US2006076790, April 2006
OPTICAL DATA CARRIER WITH A THERMOCHROMIC LAYER; WO2006027718 ; March 2006
CONTROLLED TRANSPORT AND ASSEMBLY OF NANOSTRUCTURES; WO2006034398; March 2006
POLYMER FOAMS WITH TREATED FILLERS, FABRICATION METHOD AND PRODUCTS USING SAME; WO2006033981; March 2006
|
 |
Magnetic interactions imaged in nanoscale
In a first-of-its-kind achievement, U.S. scientists say they've directly imaged the interactions between two magnetic atoms less than one nm apart. The research funded in part by the NSF and the U.S. Army Research Office is reported in Nature. More at
www.upi.com/NewsTrack/view.php?StoryID=200607 26-060608-2440r >>
Zyvex establishes nanomaterials prototyping facility
Zyvex is to establish a Nanomaterials Prototyping, Testing and Characterization Facility at the South Dakota School of Mines and Technology's Polymer Processing Center More at
www.smalltimes.com/document_brief.cfm#brief_6 >>
Elan Signs License Agreement with Abbott for NanoCrystal® Technology
Abbott has been granted US rights, in a partnership with AstraZeneca Pharmaceuticals, LP, to utilize Elan's proprietary NanoCrystal Technology to develop and commercialize a single fixed-dose combination product containing the active pharmaceutical ingredients in Abbott's TriCor® 145 (fenofibrate) and AstraZeneca's Crestor® (rosuvastatin calcium) products. More at
www.elan.com/news/full.asp?ID=879025 >>
|
|
- UK Nanotechnology Policy Review Announced
The review will cover the Government's actions in the two years since their response to the Royal Society/Royal Academy of Engineering report "Nanoscience and nanotechnologies: opportunities and uncertainties".
More >> - Nanotechnology portal for SMEs
NanoForum has set up a new portal to help SMEs find information on nanotechnology services throughout Europe.
More >> - Vision for Nanomedicine
Nanotechnology applied to medical problems can offer impressive solutions. Early diagnosis, ‘smart’ treatments and the triggering of self-healing mechanisms are crucial targets on the way to regained health.
More >>
|
|
